Mimark

Endometrics

Endometrics develops non-invasive diagnostic tests using menstrual blood samples and genomic biomarkers to detect endometriosis for women and healthcare providers.

Sakura MedTech

This company develops a tampon-shaped imaging device for cervical cancer screening to replace the traditional speculum for clinicians and their patients.

Nanopath

This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.

AOA Diagnostics

This biotech company develops AI-enabled liquid biopsy blood tests to detect early-stage ovarian cancer in symptomatic women.

MetaSight

MetaSight Diagnostics develops multi-omics liquid biopsy tests for the early detection of chronic and acute diseases for healthcare providers and patients.

Neuronostics

The company develops an EEG-based digital biomarker platform to provide objective diagnostic and prognostic support for epilepsy to healthcare providers and pharmaceutical researchers.

Endogene.Bio

This company develops a biological data platform using menstrual blood to provide diagnostics and patient stratification tools for pharmaceutical firms and healthcare providers.

Genie

This company develops non-invasive diagnostics using menstrual blood to study uterine molecular biomarkers for patients experiencing infertility.